CLINICAL TRIALS PROFILE FOR BETAINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for Betaine Hydrochloride
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00152815 ↗ | Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions | Terminated | Ontario HIV Treatment Network | Phase 2 | 2003-10-01 | The purpose of this study is to evaluate the effect of a one-year nutritional intervention with either betaine or vitamin E supplementation, or a weight reducing diet and exercise program on liver steatosis and steatohepatitis. |
NCT00152815 ↗ | Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions | Terminated | Johane Allard | Phase 2 | 2003-10-01 | The purpose of this study is to evaluate the effect of a one-year nutritional intervention with either betaine or vitamin E supplementation, or a weight reducing diet and exercise program on liver steatosis and steatohepatitis. |
NCT00226356 ↗ | Natural Supplements for Unipolar Depression | Completed | National Alliance for Research on Schizophrenia and Depression | Phase 4 | 2004-12-01 | This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression. |
NCT00226356 ↗ | Natural Supplements for Unipolar Depression | Completed | Cambridge Health Alliance | Phase 4 | 2004-12-01 | This study is being conducted to determine the clinical response rate for the regimen of L-methionine, betaine and folate for unipolar depression. |
NCT00283387 ↗ | Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria | Completed | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 | 2007-02-01 | The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients. |
NCT00283387 ↗ | Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria | Completed | Orphan Europe | Phase 2 | 2007-02-01 | The aim of this study is to assess the efficacy and safety of betaine in reducing urine oxalate excretion of Type 1 Primary Hyperoxaluria (PHI) patients. Hypothesis: Betaine will effectively reduce urine oxalate excretion in Primary Hyperoxaluria Type I patients. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Betaine Hydrochloride
Condition Name
Clinical Trial Locations for Betaine Hydrochloride
Trials by Country
Clinical Trial Progress for Betaine Hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for Betaine Hydrochloride
Sponsor Name